Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$86,115,464
+$11,454,617 QoQ
Shares Held
1,504,989
+13.9% QoQ
Ownership
0.777%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#21
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,806 across 523 Biotechnology names. BMRN ranks #43 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,115,464 | 1,504,989 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $74,660,847 | 1,321,665 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $137,617,291 | 2,315,620 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $74,764,841 | 1,380,444 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $133,505,026 | 2,428,689 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $73,721,534 | 1,042,885 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $88,106,587 | 1,340,432 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $61,168,038 | 870,224 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $98,529,490 | 1,196,763 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $88,235,141 | 1,010,249 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $90,670,662 | 940,372 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $67,378,135 | 761,507 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $76,817,631 | 886,221 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $86,396,080 | 888,483 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $113,358,385 | 1,095,356 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $69,385,511 | 818,515 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $86,542,545 | 1,044,317 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $50,347,530 | 653,016 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $38,030,430 | 430,452 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $58,591,536 | 758,074 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $61,787,150 | 740,498 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $58,990,297 | 781,225 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $57,901,617 | 660,299 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $39,647,796 | 521,133 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $70,640,023 | 572,726 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $46,199,528 | 546,740 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||